Vølund A - Search Results

1

Monomeric insulins and their experimental and clinical implications.

Brange J, Owens DR, Kang S, Vølund A. Brange J, et al. Among authors: volund a. Diabetes Care. 1990 Sep;13(9):923-54. doi: 10.2337/diacare.13.9.923. Diabetes Care. 1990. PMID: 2226110 Review.

2

Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28) in healthy subjects.

Kang S, Brange J, Burch A, Vølund A, Owens DR. Kang S, et al. Among authors: volund a. Diabetes Care. 1991 Nov;14(11):1057-65. doi: 10.2337/diacare.14.11.1057. Diabetes Care. 1991. PMID: 1797487 Clinical Trial.

3

Subcutaneous insulin absorption explained by insulin's physicochemical properties. Evidence from absorption studies of soluble human insulin and insulin analogues in humans.

Kang S, Brange J, Burch A, Vølund A, Owens DR. Kang S, et al. Among authors: volund a. Diabetes Care. 1991 Nov;14(11):942-8. doi: 10.2337/diacare.14.11.942. Diabetes Care. 1991. PMID: 1797506 Clinical Trial.

4

Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9, GluB27; AspB10; AspB28) on meal-related plasma glucose excursions in type I diabetic subjects.

Kang S, Creagh FM, Peters JR, Brange J, Vølund A, Owens DR. Kang S, et al. Among authors: volund a. Diabetes Care. 1991 Jul;14(7):571-7. doi: 10.2337/diacare.14.7.571. Diabetes Care. 1991. PMID: 1914797 Clinical Trial.

5

In vitro and in vivo potency of insulin analogues designed for clinical use.

Vølund A, Brange J, Drejer K, Jensen I, Markussen J, Ribel U, Sørensen AR, Schlichtkrull J. Vølund A, et al. Diabet Med. 1991 Nov;8(9):839-47. doi: 10.1111/j.1464-5491.1991.tb02122.x. Diabet Med. 1991. PMID: 1663018

6

Insulin analogs with improved pharmacokinetic profiles.

Brange J, Vølund A. Brange J, et al. Among authors: volund a. Adv Drug Deliv Rev. 1999 Feb 1;35(2-3):307-335. doi: 10.1016/s0169-409x(98)00079-9. Adv Drug Deliv Rev. 1999. PMID: 10837704

7

Chemical stability of insulin. 1. Hydrolytic degradation during storage of pharmaceutical preparations.

Brange J, Langkjaer L, Havelund S, Vølund A. Brange J, et al. Among authors: volund a. Pharm Res. 1992 Jun;9(6):715-26. doi: 10.1023/a:1015835017916. Pharm Res. 1992. PMID: 1409351

8

Retinopathy in newly presenting non-insulin-dependent (type 2) diabetic patients.

Owens DR, Vølund A, Jones D, Shannon AG, Jones IR, Birtwell AJ, Luzio S, Williams S, Dolben J, Creagh FN, et al. Owens DR, et al. Among authors: volund a. Diabetes Res. 1988 Oct;9(2):59-65. Diabetes Res. 1988. PMID: 3073031

9

Intranasal insulin: the effects of three dose regimens on postprandial glycaemic profiles in type II diabetic subjects.

Coates PA, Ismail IS, Luzio SD, Griffiths I, Ollerton RL, Vølund A, Owens DR. Coates PA, et al. Among authors: volund a. Diabet Med. 1995 Mar;12(3):235-9. doi: 10.1111/j.1464-5491.1995.tb00464.x. Diabet Med. 1995. PMID: 7758260 Clinical Trial.

10

Nitrendipine once or twice daily in hypertensive non-insulin-dependent diabetes mellitus.

Dolben J, Vora J, Smith H, Luzio S, Griffiths D, Vølund A, Owens DR. Dolben J, et al. Among authors: volund a. J Cardiovasc Pharmacol. 1991;18 Suppl 1:S94-7. J Cardiovasc Pharmacol. 1991. PMID: 1723468 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters